Contact this trialFirst, we need to learn more about you.
Vascular-Disrupting Agent
TOOKAD Soluble for Prostate Cancer
Recruiting1 awardPhase 2
New York, New York
This trial will look at men with localized prostate cancer who will receive TOOKAD® Soluble VTP under general anesthesia. The goal is to see if there are any Gleason grade 4 or 5 prostate cancer tumors anywhere in the prostate gland 12 months after treatment.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.